Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Strategy of Surgical Resection With Sequential Adjuvant Chemotherapy and Radiotherapy for Patients With Stage IIIA Non-small Cell Lung Cancer and N2 Disease Only in the Subaortic or Paraaortic Level, or Both

NCT02555592 is registered in ClinicalTrials.gov with Pusan National University Hospital as lead sponsor.

NCT NCT02555592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02555592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Strategy of Surgical Resection With Sequential Adjuvant Chemotherapy and Radiotherapy for Patients With Stage IIIA Non-small Cell Lung Cancer and N2 Disease Only in the Subaortic or Paraaortic Level, or Both
Lead sponsor
Pusan National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2015
Completion date
December 31, 2021
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of lymph node, effects of chemotherapy, lung cancer, surgery